Table 1.
Innovative and follow-on biosimilar and complex non-biological drugs.
Reference medication | Generic product |
---|---|
Biosimilars | |
• Betaferon®/Betaseron® | • Uribeta® (MX) |
• Rebif® | • Emaxem® (MX) |
• Xerfelan® (MX) | |
• Neuraxa® (MX) | |
• Blastoferon® (ARG) | |
• BetaIFN Clausen® (URU) | |
• Avonex® | • Jumtab® (MX) |
• Rituxan® | • Kikuzumab® (MX) |
Complex non-biological drugs | |
• Copaxone® | • Probioglat® (MX) |
MX: Mexico; ARG: Argentina; URU: Uruguay.